LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)

Spanish Lung Cancer Group

Status: Completed

Conditions: Lung Cancer; Covid-19

Study type: Observational

Funder types: Other

Identifiers

NCT04344002

GECP 20/02_GRAVID

Details and patient eligibility

About

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members.

The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.

Enrollment: 886 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with lung cancer
• Patients who have contracted COVID-19 infection

Exclusion criteria

• Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.

Trial design

886 participants in 1 patient group

lung cancer+COVID-19

Description:

lung cancer patients diagnosed with COVID-19